ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SEPN vs MRK // GROSS PROFIT MARGIN

Septerna Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: SEPN 4 — MRK 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SEPN VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SEPN MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 74.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -20.70% 20.70% -41.40 MRK /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield 5.19% 3.42% +1.77 SEPN /fcf-yield <GO>
Operating Margin -60.00% 34.30% -94.30 MRK /operating-margins <GO>
Net Profit Margin -60.00% 28.10% -88.10 MRK /net-margins <GO>
Revenue Growth (YoY) 180.00% 1.30% +178.70 SEPN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.87 5.19 +0.68 SEPN /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 MRK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 68.2 51.7 +16.50 SEPN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 18.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.11B $361.02B -$358.91B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SEPN REV MRK REV SEPN GROSS % MRK GROSS % SEPN FCF MRK FCF
FY 2025 $46.0M $65.01B — 74.8% $109.7M $12.36B
FY 2024 $1.1M $64.17B — 76.3% -$69.6M $18.10B
FY 2023 $151.0K $60.12B — — -$38.7M $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SEPN // BETA —
MRK // BETA 0.92